These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22819419)

  • 1. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy.
    Hossack T; Patel MI; Huo A; Brenner P; Yuen C; Spernat D; Mathews J; Haynes AM; Sutherland R; del Prado W; Stricker P
    J Urol; 2012 Sep; 188(3):781-5. PubMed ID: 22819419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens.
    Huo AS; Hossack T; Symons JL; PeBenito R; Delprado WJ; Brenner P; Stricker PD
    J Urol; 2012 Jun; 187(6):2044-9. PubMed ID: 22498226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy.
    Numao N; Kawakami S; Sakura M; Yoshida S; Koga F; Saito K; Masuda H; Fujii Y; Yamamoto S; Yonese J; Ishikawa Y; Fukui I; Kihara K
    BJU Int; 2012 Mar; 109(5):665-71. PubMed ID: 21939488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C; Louis P; Civantos F; Soloway MS
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy.
    Hara R; Jo Y; Fujii T; Kondo N; Yokoyoma T; Miyaji Y; Nagai A
    Urology; 2008 Feb; 71(2):191-5. PubMed ID: 18308081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of transrectal versus transperineal prostate biopsy.
    Miller J; Perumalla C; Heap G
    ANZ J Surg; 2005; 75(1-2):48-50. PubMed ID: 15740517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category? A comparative analysis.
    Scott S; Samaratunga H; Chabert C; Breckenridge M; Gianduzzo T
    BJU Int; 2015 Oct; 116 Suppl 3():26-30. PubMed ID: 26260531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy.
    Vis AN; Boerma MO; Ciatto S; Hoedemaeker RF; Schröder FH; van der Kwast TH
    Urology; 2000 Oct; 56(4):617-21. PubMed ID: 11018617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
    Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
    Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
    Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
    J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.
    Kassouf W; Nakanishi H; Ochiai A; Babaian KN; Troncoso P; Babaian RJ
    J Urol; 2007 Jul; 178(1):111-4. PubMed ID: 17499289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for repeat prostate biopsy: predictors of positive biopsy and additional biopsy location.
    Katto K; Takahashi M; Taue R; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Nishitani MA; Kanayama HO
    Urol Int; 2008; 81(2):173-8. PubMed ID: 18758215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
    Thomas GV; Schrage MI; Rosenfelt L; Kim JH; Salur G; deKernion JB; Dorey F; Said J; Reiter RE
    J Urol; 2000 Dec; 164(6):1987-91. PubMed ID: 11061897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.